< Back | |
09 Jan 2015 | |
The Exchange had sought clarification from Cadila Healthcare Ltd with respect to news appearing in Business Standard on January 09, 2015 titled "Cadila recalls 19,536 bottles of cough treatment drug in US."<BR><BR>Cadila Healthcare Ltd replied stating "The recall by our US subsidiary was voluntary and a class-II type recall. The Company does not envisage any material impact". | |
View all announcements for CADILA HEALTHCARE LTD. | Source: BSE India |